Kerr A - Search Results

1

Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter?

Wells S, Poppe K, Selak V, Kerr A, Pylypchuk R, Wu B, Chan WC, Grey C, Mehta S, Gentles DG, Jackson R. Wells S, et al. Among authors: kerr a. N Z Med J. 2018 May 18;131(1475):10-20. N Z Med J. 2018. PMID: 29771897

2

Clinical features of individuals with cystic fibrosis in New Zealand.

Wesley A, Dawson K, Hewitt C, Kerr A. Wesley A, et al. Among authors: kerr a. N Z Med J. 1993 Feb 10;106(949):28-30. N Z Med J. 1993. PMID: 8464584

3

Secondary prevention in coronary artery disease patients in South Auckland: moving targets and the current treatment gap.

El-Jack S, Kerr A. El-Jack S, et al. Among authors: kerr a. N Z Med J. 2003 Nov 7;116(1185):U664. N Z Med J. 2003. PMID: 14615806

4

The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.

Sinclair G, Kerr A. Sinclair G, et al. Among authors: kerr a. N Z Med J. 2006 Nov 17;119(1245):U2312. N Z Med J. 2006. PMID: 17146487

5

The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).

Wells S, Kerr A, Broad J, Riddell T, Kenealy T, Jackson R. Wells S, et al. Among authors: kerr a. N Z Med J. 2007 Sep 7;120(1261):U2712. N Z Med J. 2007. PMID: 17853933

6

Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?

Kerr AJ, Broad J, Wells S, Riddell T, Jackson R. Kerr AJ, et al. Heart. 2009 Feb;95(2):125-9. doi: 10.1136/hrt.2007.140905. Epub 2008 Apr 1. Heart. 2009. PMID: 18381374

7

Ethnic and socioeconomic disparities in the prevalence of cardiovascular disease in New Zealand.

Chan WC, Wright C, Riddell T, Wells S, Kerr AJ, Gala G, Jackson R. Chan WC, et al. N Z Med J. 2008 Nov 7;121(1285):11-20. N Z Med J. 2008. PMID: 19079433

8

The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT CVD-9.

Kerr AJ, McLachlan A, Furness S, Broad J, Riddell T, Jackson R, Wells S. Kerr AJ, et al. N Z Med J. 2008 Nov 7;121(1285):20-33. N Z Med J. 2008. PMID: 19079434

9

Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.

Colvine K, Kerr AJ, McLachlan A, Gow P, Kumar S, Ly J, Wiltshire C, Robinson E, Dalbeth N. Colvine K, et al. Among authors: kerr aj. N Z Med J. 2008 Nov 7;121(1285):73-81. N Z Med J. 2008. PMID: 19079439 Clinical Trial.

10

QRISK or Framingham for predicting cardiovascular risk?

Jackson R, Marshall R, Kerr A, Riddell T, Wells S. Jackson R, et al. Among authors: kerr a. BMJ. 2009 Jul 7;339:b2673. doi: 10.1136/bmj.b2673. BMJ. 2009. PMID: 19584410 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,403 results

Search Page

Filters